Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm

Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

17 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–10 of 10 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03651206	Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib(ROCSAN)	recruiting	Phase 2 / Phase 3	138	ARCAGY/ GINECO GROUPOTHER	3	Sep 9, 2026	clinicaltrials
NCT07467772	Ph 2 Elacestrant in ER Positive Uterine Sarcomas	recruiting	Phase 2	30	Dana-Farber Cancer InstituteOTHER	1	May 22, 2026	clinicaltrials
NCT05156268	A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma	completed	Phase 2	26	Memorial Sloan Kettering Cancer CenterOTHER	1	Apr 27, 2026	clinicaltrials
NCT02874430	Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer

Data updated 21 days agoSource updated Sep 9, 2026source: clinicaltrials